Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy
NCT ID: NCT00482586
Last Updated: 2015-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
137 participants
OBSERVATIONAL
2003-10-31
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This clinical trial is gathering information about quality of life over time from patients with liver cancer treated with image-guided therapy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
National Registry and Blood Bank of Patients With Liver Cancer
NCT00482365
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
NCT02626312
Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients
NCT04933435
MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer
NCT02578602
Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer
NCT00739167
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Develop a data repository for clinical and health-related quality of life outcome measures in patients with hepatic malignancies treated with image-guided therapies.
OUTLINE: This is a pilot, prospective, longitudinal study.
Patients complete a standard questionnaire assessing health-related quality of life at baseline, during routine follow-up care after image-guided therapy, and then annually thereafter. Health and disease status and the development of other illnesses are assessed by medical record review.
PROJECTED ACCRUAL: Not specified
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Image-guided Therapy
Patients undergoing Image-guided Therapy of Hepatic Neoplasms.
medical chart review
Review the medical charts of patients with hepatic neoplasms who undergo Image-guided Therapy.
questionnaire administration
Patients with hepatic neoplasms who undergo Image-guided Therapy
quality-of-life assessment
Patients with hepatic neoplasms who undergo Image-guided Therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
medical chart review
Review the medical charts of patients with hepatic neoplasms who undergo Image-guided Therapy.
questionnaire administration
Patients with hepatic neoplasms who undergo Image-guided Therapy
quality-of-life assessment
Patients with hepatic neoplasms who undergo Image-guided Therapy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Undergoing concurrent image-guided therapy for hepatic malignancies using any of the following imaging techniques:
* X-ray
* Ultrasound
* MRI
* CT scan
* Nuclear medicine imaging
PATIENT CHARACTERISTICS:
* Not specified
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Vanderbilt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Steven Meranze
Professor of Radiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Steven G. Meranze, MD
Role: STUDY_CHAIR
Vanderbilt-Ingram Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt-Ingram Cancer Center - Cool Springs
Nashville, Tennessee, United States
Vanderbilt-Ingram Cancer Center at Franklin
Nashville, Tennessee, United States
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VU-VICC-GI-0372
Identifier Type: OTHER
Identifier Source: secondary_id
VU-VICC-IRB-020874
Identifier Type: OTHER
Identifier Source: secondary_id
CDR0000546520
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.